GlassScriptPhysician profile
Manaf Younis
NPI 1629575584
$9,253.03
in general payments reported to CMS, 2019-2025
7 companies · $4,521 in 2025
The $4,521 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,570 · 2021: $46.86 · 2022: $289 · 2024: $2,826 · 2025: $4,521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,803 · Food and Beverage: $1,544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,802.52 |
| Food and Beverage | $1,544.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,373.72 | 2024-2025 | Proclaim, Eterna, Octrode |
| Spineology INC. | $2,235.16 | 2025 | Optimesh Expandable Interbody Fusion System |
| Stryker Corporation | $1,503.35 | 2025 | Core, N/A |
| Si-Bone, INC. | $1,234.41 | 2024-2025 | |
| Gotham Surgical Solutions & Devices, INC. | $1,208.00 | 2020 | |
| Alon Medical Technology | $362.46 | 2020 | |
| Medtronic, INC. | $335.93 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manaf Younis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.